Review The SDS Document
DOWNLOADProduct Details
Formula
C20H27N5O2
MW
369.47
Purity
>97%
Solubility (DMSO Mg/MI)
18
Bio Chemical Notes
Approved for the treament of intermittent claudication in the US since 1999, Cilostazol is a PDE3 inhibitor. Ref: Cardiovascular Therapeutics 2001; 19 (4); 369-389.
![Cilostazol [STAGING] Key Organics](https://staging.keyorganics.net/app/uploads/2026/01/Key-Organics-40th-logo-strip-1.png)
